These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 35806905)
1. Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives. Madhavan Y; Sai KV; Shanmugam DK; Manimaran A; Guruviah K; Mohanta YK; Venugopal DC; Mohanta TK; Sharma N; Muthupandian S J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806905 [TBL] [Abstract][Full Text] [Related]
2. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease. Rao C; R M J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India. Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032 [TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients. Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870 [TBL] [Abstract][Full Text] [Related]
5. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Rudrabhatla PK; Reghukumar A; Thomas SV Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787 [TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic. Chandley P; Subba P; Rohatgi S Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016154 [TBL] [Abstract][Full Text] [Related]
7. Accidental finding of COVID-associated mucormycosis (CAM) in a patient presenting as toothache: A case report and review of literature. Gb P; B K; Sivapathasundharam B; Manodh P; Raj AT; Ghosh S; Dhungel S Clin Case Rep; 2023 May; 11(5):e7292. PubMed ID: 37151941 [TBL] [Abstract][Full Text] [Related]
8. A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM). Osman NA; Anwar MM; Singh B; Gupta GK; Rabie AM J Egypt Public Health Assoc; 2023 Mar; 98(1):4. PubMed ID: 36859556 [TBL] [Abstract][Full Text] [Related]
10. Early Surgical Intervention Followed by Antifungals in Rhino-Orbital Mucormycosis in Patients With COVID-19 Favors Clinical Outcome: A Case Series. Barman Roy D; Gupta V; Biswas A; Verma M Cureus; 2021 Aug; 13(8):e17178. PubMed ID: 34548980 [TBL] [Abstract][Full Text] [Related]
11. Two Uncommon Presentations of COVID-19-Associated Mucormycosis. Rathna R; D'Souza C; D'Silva C; Joseph JM; Varghese AK Cureus; 2022 Jan; 14(1):e21229. PubMed ID: 35186527 [TBL] [Abstract][Full Text] [Related]
12. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic. Kamrul-Hasan AB; Selim S Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483 [TBL] [Abstract][Full Text] [Related]
13. Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies. Sahu RK; Salem-Bekhit MM; Bhattacharjee B; Almoshari Y; Ikbal AMA; Alshamrani M; Bharali A; Salawi A; Widyowati R; Alshammari A; Elbagory I Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572661 [TBL] [Abstract][Full Text] [Related]
14. Mucormycosis - resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports. Upadhyay S; Bharara T; Khandait M; Chawdhry A; Sharma BB World J Clin Cases; 2021 Dec; 9(36):11338-11345. PubMed ID: 35071564 [TBL] [Abstract][Full Text] [Related]
15. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. Riley TT; Muzny CA; Swiatlo E; Legendre DP Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416 [TBL] [Abstract][Full Text] [Related]
17. Mucor in a Viral Land: A Tale of Two Pathogens. Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566 [TBL] [Abstract][Full Text] [Related]
18. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report. Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254 [TBL] [Abstract][Full Text] [Related]
19. [Mucormycosis: therapeutic news]. Pilmis B; Lanternier F; Lortholary O Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India. Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]